Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 George Street
Suite 786B
New Haven, CT 06511Phone+1 203-737-6403
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2002 - 2005
- Baylor College of MedicineResidency, Internal Medicine, 1999 - 2002
- All India Institute of Medical SciencesClass of 1998
Certifications & Licensure
- CT State Medical License 2013 - 2025
- CO State Medical License 2008 - 2015
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 63 citationsSide population cells as prototype of chemoresistant, tumor-initiating cells.Vinitha Richard, Madhumathy G. Nair, T. R. Santhosh Kumar, M. Radhakrishna Pillai
Biomed Research International. 2013-11-04 - 35 citationsDetailed Comparison of the Protein-Ligand Docking Efficiencies of GOLD, a Commercial Package and ArgusLab, a Licensable FreewareSaju Joy, Parvathy S Nair, Ramkumar Hariharan, M. Radhakrishna Pillai
In Silico Biology. 2006-01-01 - 37 citationsBis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine photodynamic therapy disrupts redox homeostasis and induce mitochondria-mediated apoptosis in human breast cancer cells.P. S. Saneesh Babu, Prasad M. Manu, T. Jayaram Dhanya, Pradhan Tapas, R. Nair Meera
Scientific Reports. 2017-02-07
Abstracts/Posters
- Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center ExperienceManoj M Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- U2AF1 Driver Mutations in Hematopoietic Disorders Alter but Do Not Abrogate RNA Binding and Enlighten Structural Dependencies of the U2AF-RNA ComplexManoj M Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AMLManoj M Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
External Links
- Pillai Labhttp://medicine.yale.edu/lab/pillai/index.aspx
- Manoj Pillaihttp://medicine.yale.edu/lab/pillai/people//manoj_pillai.profile?source=news
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: